Completed NA INTERVENTIONAL NCT00279279

PREPARE - Primary Prevention Parameters Evaluation

Sponsor: Medtronic

Conditions Fibrillation, Ventricular Implantable Cardioverter Defibrillator (ICD) Syncope Tachycardia, Ventricular

Updated 6 times since 2017 Last updated: Oct 25, 2006 Started: Oct 31, 2003 Completion: May 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Fibrillation, Ventricular and Implantable Cardioverter Defibrillator (ICD) and is currently completed. Medtronic leads this study, which shows 6 recorded versions since 2003 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Oct 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medtronic
Medtronic Cardiac Rhythm and Heart Failure

Data source: Medtronic Cardiac Rhythm and Heart Failure

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Amarillo, United States , Bethlehem, United States , Birmingham, United States , Boston, United States , Buffalo, United States , Columbia, United States , Columbus, United States , Elyria, United States , Fort Lauderdale, United States , Jacksonville, United States and 21 more locations